ICAM1 and arthritic joint disease: We previously demonstrated alterations in sCD18 complexes in the blood and synovial fluid of patients with arthritis and showed that sCD18 binding to ICAM-1 could be an anti-inflammatory regulatory mechanism in the immune system.